Outcomes of Descemet Membrane Endothelial Keratoplasty for Vitrectomized Eyes with Sutured Posterior Chamber Intraocular Lens

Table 2

Profiles of the enrolled patients (vitrectomized group).

Case	Sex	Age	OD/OS	Etiology for PPV	Previous surgeries	Preop BSCVA	Preop CCT (μm)	Treatment before DMEK
1	F	79	OD	PEX	PEA, PPV + IOLs	20/2000	793
2	M	79	OS	PEX	ICCE, PPV + IOLs	20/1000	724
3	F	74	OS	PEX	ICCE + PPV + IOLs, DSAEK	20/200	836	ASR
4	F	52	OS	Extended CL wearing	Cataract aspiration, PPV + IOLs	20/50	672
5	F	64	OS	Dropped IOL	PPV + IOLs	20/2000	734	ASR
6	F	56	OS	RRD	PPV + SOi, SOr + IOLs	20/50	757
7	M	79	OD	RRD	PPV + SOi, SOr + IOLs	20/500	939	ASR
8	M	74	OD	Endophthalmitis	PPV + IOLr + SOi, SOr + IOLs	20/100	658	ASR

ASR: anterior segment reconstruction; BSCVA: best spectacle-corrected visual acuity; CCT: central corneal thickness; DMEK: Descemet membrane endothelial keratoplasty; ICCE: intracapsular cataract extraction; IOLr: removal of intraocular lens; IOLs: transscleral-sutured posterior chamber intraocular lens implantation; OD: right eye; OS: left eye; PEA: phacoemulsification and aspiration; PEX: pseudoexfoliation syndrome; PPV: pars plana vitrectomy; Preop: preoperative; RRD: rhegmatogenous retinal detachment; SOi: silicone oil injection; SOr: silicon oil extraction.